Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Shuang-Xue Yuan"'
1
Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells
Autor: Ke Wu, Yu Yu, Wen-Juan Sun, Qiu-Xiang Wu, Chun-Mei Ren, Shuang-Xue Yuan, Bai-Cheng He
Publikováno v: Oncology Reports. 35:3341-3348
Oridonin (ORI) has been reported as an antiproliferation and apoptosis-inducing natural product in various cancer cells. However, the exact molecular mechanism underlying these effects remains unclear. In the present study, we demonstrated the antipr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e703c9d65f82deba5fd91dd72d5d861
https://doi.org/10.3892/or.2016.4735
Zobrazit plný text záznamu
2
BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer
Autor: Yu-Hua Zeng, Qiu-Xiang Wu, Ke Wu, Shuang-Xue Yuan, Bai-Cheng He, Wen-Juan Sun, Chun-Mei Ren, Yang Li, Ying Shao, Qian-Zhao Chen, Dong-Xu Wang, Jun-Qin Yang, Pu Zhang, Yu Yu, Yan Bai
Publikováno v: Oncology Reports. 35:939-947
Colon cancer is one of the most common malignancies of the digestive system. Although more effective therapeutic strategies have been developed in the last decades, there is still a great clinical need to explore new treatment regimens for colon canc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9119dc5878881ca4c3ae65ffa1785bb0
https://doi.org/10.3892/or.2015.4407
Zobrazit plný text záznamu
3
Antiproliferation effect of evodiamine in human colon cancer cells is associated with IGF-1/HIF-1α downregulation
Autor: Zhen-Hua Chen, Wen-Juan Sun, Qiu-Xiang Wu, Ying Shao, Bai-Cheng He, Yu Yu, Yu-Hua Zeng, Ke Wu, Jun Huang, Qian-Zhao Chen, Yang Li, Dong-Xu Wang, Shuang‑Xue Yuan, Chun-Mei Ren
Publikováno v: Oncology Reports. 34:3203-3211
Colon cancer is one of the most common malignancies. Although the current treatment regimes for colon cancer have been well-developed in the past decades, the prognosis remains still undesirable. It is still urgent to explore new treatment strategies
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fd529c5baa36a4aa1a2b8bb749bde67
https://doi.org/10.3892/or.2015.4309
Zobrazit plný text záznamu
4
Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK
Autor: Ke Wu, Qiu-Xiang Wu, Ying Shao, Yu Yu, Qian-Zhao Chen, Yu-Hua Zeng, Bai-Cheng He, Yang Li, Jun-Qin Yang, Wen-Juan Sun, Chun-Mei Ren, Shuang-Xue Yuan
Publikováno v: Oncology reports. 35(5)
Oridonin (ORI), a diterpenoid purified from Rabdosia rubescens, has been reported as a promising chemotherapy drug for colon cancer treatment; yet, the precise mechanisms underlying this anticancer activity remain unclear. In the present study, we in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3413072f6b821850806300c3fed17d49
https://pubmed.ncbi.nlm.nih.gov/26986967
Zobrazit plný text záznamu
5
The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation
Autor: Yang Liu, Zhong-Liang Deng, Ke Wu, Ying-Zi Liu, Liang Chen, Bai-Cheng He, Liangjun Yin, Zi-Jun Meng, Jun Huang, Xin Wang, Shuang-Xue Yuan, Dong-Xu Wang, Jun-Qin Yang, Jinyong Luo, Wen-Juan Sun, Guo-Wei Zuo
Publikováno v: International journal of oncology. 45(1)
Colon cancer is one of the most common malignancies and the treatments for colon cancer have been developed substantially in the last decades, but there is still a great clinical need to explore new treatment regimens due to the undesirable prognosis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63fe5ca88729c8ccb9fa0710663d4413
https://pubmed.ncbi.nlm.nih.gov/24756222
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje